Apexigen, Inc.

The momentum for this stock is not very good. Apexigen, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Apexigen, Inc..
Log in to see more information.
APGN Fundamental Data by TradingView

News

Pyxis Oncology successfully completes acquisition of Apexigen
Pyxis Oncology successfully completes acquisition of Apexigen

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Short Interest in Apexigen, Inc. (NASDAQ:APGN) Decreases By 18.8%
Short Interest in Apexigen, Inc. (NASDAQ:APGN) Decreases By 18.8%

Ticker Report Apexigen, Inc. (NASDAQ:APGN Get Free Report) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totalling 64,500 shares, a drop of 18.8% from the July 15th total of 79,400 shares. Based on an average daily volume of 256,000 shares, ...\n more…

Contrasting Apexigen (NASDAQ:APGN) and Catalyst Biosciences (NASDAQ:CBIO)
Contrasting Apexigen (NASDAQ:APGN) and Catalyst Biosciences (NASDAQ:CBIO)

Zolmax Apexigen (NASDAQ:APGN Free Report) and Catalyst Biosciences (NASDAQ:CBIO Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, ...\n more…

Short Interest in Apexigen, Inc. (NASDAQ:APGN) Declines By 64.8%
Short Interest in Apexigen, Inc. (NASDAQ:APGN) Declines By 64.8%

Ticker Report Apexigen, Inc. (NASDAQ:APGN Free Report) was the target of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 87,900 shares, a decrease of...\n more…

Financial Comparison: Apexigen (NASDAQ:APGN) & AnaptysBio (NASDAQ:ANAB)
Financial Comparison: Apexigen (NASDAQ:APGN) & AnaptysBio (NASDAQ:ANAB)

Ticker Report AnaptysBio (NASDAQ:ANAB Free Report) and Apexigen (NASDAQ:APGN Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, ...\n more…

Apexigen, Inc. (NASDAQ:APGN) Short Interest Up 229.7% in May
Apexigen, Inc. (NASDAQ:APGN) Short Interest Up 229.7% in May

Zolmax Apexigen, Inc. (NASDAQ:APGN Get Rating) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 249,900 shares, a growth of 229.7% from the May 15th total of 75,800 shares. Currently, 1.2% of the shares of the stock are short sold. Based on an...\n more…